Machine learning-based recommendation system for disease-drug material and adverse drug reaction: Comparative review

Author(s):  
Kretika Tiwari ◽  
Dileep Kumar Singh
Drug Safety ◽  
2019 ◽  
Vol 42 (6) ◽  
pp. 721-725 ◽  
Author(s):  
Christopher McMaster ◽  
David Liew ◽  
Claire Keith ◽  
Parnaz Aminian ◽  
Albert Frauman

2021 ◽  
Author(s):  
Milad Besharatifard ◽  
Zahra Ghorbanali ◽  
Fatemeh Zare-Mirakabad

Identifying and controlling adverse drug reactions is a complex problem in the pharmacological field. Despite the studies done in different laboratory stages, some adverse drug reactions are recognized after being released, such as Rosiglitazone. Due to such experiences, pharmacists are now more interested in using computational methods to predict adverse drug reactions. In computational methods, finding and representing appropriate drug and adverse reaction features are one of the most critical challenges. Here, we assess fingerprint and target as drug features; and phenotype and unified medical language system as adverse reaction features to predict adverse drug reaction. Meanwhile, we show that drug and adverse reaction features represented by similarity vectors can improve adverse drug prediction. In this regard, we propose four frameworks. Two frameworks are based on random forest classification and neural networks as machine learning methods called F_RF and F_NN, respectively. The rest of them improve two state-of-art matrix factorization models, CS and TMF, by considering target as a drug feature and phenotype as an adverse reaction feature. However, machine learning frameworks with fewer drug and adverse reaction features are more accurate than matrix factorization frameworks. In addition, the F_RF framework performs significantly better than F_NN with ACC = %89.15, AUC = %96.14 and AUPRC = %92.9. Next, we contrast F_RF with some well-known models designed based on similarity vectors of drug and adverse reaction features. Unlike other methods, we do not remove rare reactions from the data set in our frameworks. The data and implementation of proposed frameworks are available at http://bioinformatics.aut.ac.ir/ADRP-ML-NMF/.


Drug Safety ◽  
2019 ◽  
Vol 42 (6) ◽  
pp. 807-807
Author(s):  
Christopher McMaster ◽  
David Liew ◽  
Claire Keith ◽  
Parnaz Aminian ◽  
Albert Frauman

Author(s):  
Duc Anh Nguyen ◽  
Canh Hao Nguyen ◽  
Hiroshi Mamitsuka

Abstract Motivation Adverse drug reaction (ADR) or drug side effect studies play a crucial role in drug discovery. Recently, with the rapid increase of both clinical and non-clinical data, machine learning methods have emerged as prominent tools to support analyzing and predicting ADRs. Nonetheless, there are still remaining challenges in ADR studies. Results In this paper, we summarized ADR data sources and review ADR studies in three tasks: drug-ADR benchmark data creation, drug–ADR prediction and ADR mechanism analysis. We focused on machine learning methods used in each task and then compare performances of the methods on the drug–ADR prediction task. Finally, we discussed open problems for further ADR studies. Availability Data and code are available at https://github.com/anhnda/ADRPModels.


2021 ◽  
Author(s):  
Yu Rang Park

UNSTRUCTURED An adverse drug reaction (ADR) is an unintended response induced by a drug. It is important to determine the association between drugs and ADRs. There are many methods to demonstrate this association. This systematic review aimed to examine the analysis tools by considering original articles that introduced statistical and machine learning methods for predicting ADRs in humans. A systematic literature review of EMBASE and PubMed was conducted based on articles published from January 2015 to March 2020. The keywords were statistical, machine learning, and deep learning methods for the detection of ADR signals in the title and abstract. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement guidelines. In total, 72 articles were included in the current systematic review; of these, 51 and 21 addressed statistical and machine learning methods, respectively. This study provides a graphical overview of data-driven methods for detecting ADRs with multiple data sources for patient drug safety.


Sign in / Sign up

Export Citation Format

Share Document